Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)

22. maj 2026 opdateret af: Flora Peyvandi, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.

Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.

This is a monocentric, national study including two patient cohorts:

Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.

Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.

Participants will:

  • Undergo clinical evaluation, including internal medicine and neurological assessments
  • Provide blood and urine samples for laboratory analyses
  • Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
  • Receive psychological/neuropsychological evaluations
  • Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

79

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Milano
      • Milan, Milano, Italien, 20122
        • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • aged ≥18 years
  • with a confirmed diagnosis of TTP (either congenital or acquired immune-mediated TTP)
  • referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) in acute phase of a first or recurrent episode (cohort 1) or referred at our outpatient clinic (S.C. Medicina - Emostasi e Trombosi) during clinical remission at more than 3 months from the clinical response of the previous episode (cohort 2). In any case, patient enrolment will always take place in the S.C. Medicina - Emostasi e Trombosi
  • providing a signed informed consent

Exclusion Criteria:

- Patients who do not possess the above inclusion criteria or have known contraindications to the instrumental exam included in the study (MRI).

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Diagnostisk
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Andet: Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
Andet: Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Prevalence
Tidsramme: From enrollment to the last visit (after 36 months from T0)
Prevalence of microcirculation damage in iTTP patients compared to general population
From enrollment to the last visit (after 36 months from T0)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cerebral microcirculation lesions
Tidsramme: From enrollment to the last visit (after 36 months from T0)
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
From enrollment to the last visit (after 36 months from T0)
Retinal microcirculation changes
Tidsramme: From enrollment to the last visit (after 36 months from T0)
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
From enrollment to the last visit (after 36 months from T0)
Peripheral microcirculation
Tidsramme: From enrollment to the last visit (after 36 months from T0)
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
From enrollment to the last visit (after 36 months from T0)
Association between cerebral MRI lesions and cognitive or psychological symptoms
Tidsramme: From enrollment to the last visit (36 months from T0)
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
From enrollment to the last visit (36 months from T0)
Modification of preclinical biomarkers
Tidsramme: From enrollment to the last visit (36 months from T0)
Explore the modification of preclinical biomarkers over time at different stage of the disease
From enrollment to the last visit (36 months from T0)
Associations between preclinical biomarkers and microcirculatory damage
Tidsramme: From enrollment to the last visit (36 months from T0)
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
From enrollment to the last visit (36 months from T0)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

28. februar 2026

Primær færdiggørelse (Anslået)

31. januar 2031

Studieafslutning (Anslået)

31. januar 2032

Datoer for studieregistrering

Først indsendt

22. maj 2026

Først indsendt, der opfyldte QC-kriterier

22. maj 2026

Først opslået (Faktiske)

29. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

29. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

22. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med TTP - Trombotisk trombocytopenisk purpura

Kliniske forsøg med Factor VIII (FVIII)

Abonner